Short-term effects on tolerability of inhaled hypertonic saline solution and hypertonic saline plus hyaluronic acid in cystic fibrosis patients
Keywords:
cystic fibrosis, hyaluronic acid, hypertonic saline, tolerability, pulmonary function test, airway clearance techniquesAbstract
Introduction Inhaled Hypertonic saline (HS) solution has been proposed as a new therapy to increase the hydration of the airway surface in patients with CF. Some adverse events such as coughing, narrowing of the airways and salty taste could be modified by the combination of the solution with Hyaluronic acid. Materials and methods 30 children with cystic fibrosis received inhaled HS and inhaled HSHA for two consecutive days. The measurement of predicted FEV1% was performed before the treatment and 30 minutes post inhalation. Outcome The primary outcome was the evaluation of Forced Expiratory volume at first second (FEV1) % of predicted values measured before and after drug exposure (inhalation to HTS and HSHA respectively). Conclusions The administration of HS and HSHA showed a comparable safety profile.Downloads
Issue
Section
License
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.